148 related articles for article (PubMed ID: 2968227)
1. Ipratropium in patients with COPD receiving cholinesterase inhibitors.
Liggett SB; Daughaday CC; Senior RM
Chest; 1988 Jul; 94(1):210-2. PubMed ID: 2968227
[TBL] [Abstract][Full Text] [Related]
2. [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].
Robinet G; Leroyer C; Andre J; Dewitte JD; Clavier J
Rev Pneumol Clin; 1989; 45(4):161-3. PubMed ID: 2533994
[TBL] [Abstract][Full Text] [Related]
3. Air-flow limitation in myasthenia gravis. The effect of acetylcholinesterase inhibitor therapy on air-flow limitation.
Shale DJ; Lane DJ; Davis CJ
Am Rev Respir Dis; 1983 Oct; 128(4):618-21. PubMed ID: 6226224
[TBL] [Abstract][Full Text] [Related]
4. Ipratropium bromide in COPD and asthma.
Atsmon J
Am J Med Sci; 1988 Aug; 296(2):140-2. PubMed ID: 2969679
[No Abstract] [Full Text] [Related]
5. Ipratropium: an alternative for bronchodilator therapy.
Lynn MM; Holdcroft C
Nurse Pract; 1990 May; 15(5):44-8. PubMed ID: 2140435
[No Abstract] [Full Text] [Related]
6. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
[TBL] [Abstract][Full Text] [Related]
7. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
LeDoux EJ; Morris JF; Temple WP; Duncan C
Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
[TBL] [Abstract][Full Text] [Related]
9. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
Patrick DM; Dales RE; Stark RM; Laliberte G; Dickinson G
Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
[TBL] [Abstract][Full Text] [Related]
10. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
Sieb JP; Köhler W
Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
[TBL] [Abstract][Full Text] [Related]
11. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
12. Use of ipratropium bromide in obstructive lung disease.
Mann KV; Leon AL; Tietze KJ
Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
Curzon PG; Martin MA; Cooke NJ; Muers MF
Thorax; 1983 Aug; 38(8):601-4. PubMed ID: 6225214
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease].
Malinowski R; Frank-Piskorska A; Wasek Z; Koczorowski T
Pneumonol Pol; 1986 Mar; 54(3):91-5. PubMed ID: 2942842
[No Abstract] [Full Text] [Related]
15. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
Stauder J; Flasch CI
Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
[No Abstract] [Full Text] [Related]
16. Combination therapy--a review of clinical studies.
Rudolf M
Postgrad Med J; 1984; 60 Suppl 1():9-12. PubMed ID: 6145152
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
[TBL] [Abstract][Full Text] [Related]
18. Ipratropium.
Med Lett Drugs Ther; 1987 Jul; 29(745):71-2. PubMed ID: 2885730
[No Abstract] [Full Text] [Related]
19. [Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)].
Schultze-Werninghaus G; Gonsior E; Meier-Sydow J
Dtsch Med Wochenschr; 1979 Aug; 104(31):1098-104. PubMed ID: 37060
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of Parkinson's disease and myasthenia gravis: a case report.
Kao KP; Kwan SY; Lin KP; Chang YC
Clin Neurol Neurosurg; 1993 Jun; 95(2):137-9. PubMed ID: 8344012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
